nodes	percent_of_prediction	percent_of_DWPC	metapath
Betaxolol—CYP2D6—Gefitinib—lung cancer	0.0772	0.229	CbGbCtD
Betaxolol—CYP2D6—Vinorelbine—lung cancer	0.0594	0.176	CbGbCtD
Betaxolol—CYP1A2—Erlotinib—lung cancer	0.0554	0.164	CbGbCtD
Betaxolol—CYP2D6—Erlotinib—lung cancer	0.0456	0.135	CbGbCtD
Betaxolol—CYP1A2—Etoposide—lung cancer	0.0401	0.119	CbGbCtD
Betaxolol—CYP2D6—Vinblastine—lung cancer	0.0366	0.109	CbGbCtD
Betaxolol—CYP2D6—Doxorubicin—lung cancer	0.0225	0.0668	CbGbCtD
Betaxolol—Chlorphenesin—PTGS2—lung cancer	0.000711	0.235	CrCbGaD
Betaxolol—Atenolol—ABCB1—lung cancer	0.000605	0.2	CrCbGaD
Betaxolol—Acebutolol—ABCB1—lung cancer	0.000558	0.184	CrCbGaD
Betaxolol—Metoprolol—ABCB1—lung cancer	0.000471	0.155	CrCbGaD
Betaxolol—Propranolol—CYP1A1—lung cancer	0.000447	0.148	CrCbGaD
Betaxolol—Propranolol—ABCB1—lung cancer	0.000238	0.0785	CrCbGaD
Betaxolol—Cough—Docetaxel—lung cancer	0.000199	0.000358	CcSEcCtD
Betaxolol—Angina pectoris—Doxorubicin—lung cancer	0.000199	0.000358	CcSEcCtD
Betaxolol—Insomnia—Paclitaxel—lung cancer	0.000198	0.000357	CcSEcCtD
Betaxolol—Epistaxis—Methotrexate—lung cancer	0.000198	0.000356	CcSEcCtD
Betaxolol—Hypersensitivity—Irinotecan—lung cancer	0.000198	0.000356	CcSEcCtD
Betaxolol—Paraesthesia—Paclitaxel—lung cancer	0.000197	0.000354	CcSEcCtD
Betaxolol—Bronchitis—Doxorubicin—lung cancer	0.000196	0.000353	CcSEcCtD
Betaxolol—Agranulocytosis—Methotrexate—lung cancer	0.000196	0.000353	CcSEcCtD
Betaxolol—Dyspnoea—Paclitaxel—lung cancer	0.000195	0.000352	CcSEcCtD
Betaxolol—Decreased appetite—Etoposide—lung cancer	0.000194	0.00035	CcSEcCtD
Betaxolol—Chest pain—Docetaxel—lung cancer	0.000194	0.000349	CcSEcCtD
Betaxolol—Myalgia—Docetaxel—lung cancer	0.000194	0.000349	CcSEcCtD
Betaxolol—Arthralgia—Docetaxel—lung cancer	0.000194	0.000349	CcSEcCtD
Betaxolol—Nausea—Vinorelbine—lung cancer	0.000194	0.000348	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Etoposide—lung cancer	0.000193	0.000347	CcSEcCtD
Betaxolol—Dyspepsia—Paclitaxel—lung cancer	0.000193	0.000347	CcSEcCtD
Betaxolol—Body temperature increased—Cisplatin—lung cancer	0.000193	0.000347	CcSEcCtD
Betaxolol—Asthenia—Irinotecan—lung cancer	0.000193	0.000347	CcSEcCtD
Betaxolol—Fatigue—Etoposide—lung cancer	0.000193	0.000347	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000192	0.000346	CcSEcCtD
Betaxolol—Pain—Etoposide—lung cancer	0.000191	0.000344	CcSEcCtD
Betaxolol—Constipation—Etoposide—lung cancer	0.000191	0.000344	CcSEcCtD
Betaxolol—Dysuria—Doxorubicin—lung cancer	0.000191	0.000343	CcSEcCtD
Betaxolol—Decreased appetite—Paclitaxel—lung cancer	0.000191	0.000343	CcSEcCtD
Betaxolol—Dry mouth—Docetaxel—lung cancer	0.00019	0.000341	CcSEcCtD
Betaxolol—Upper respiratory tract infection—Doxorubicin—lung cancer	0.00019	0.000341	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000189	0.000341	CcSEcCtD
Betaxolol—Fatigue—Paclitaxel—lung cancer	0.000189	0.00034	CcSEcCtD
Betaxolol—Asthenia—Gemcitabine—lung cancer	0.000188	0.000338	CcSEcCtD
Betaxolol—Constipation—Paclitaxel—lung cancer	0.000187	0.000337	CcSEcCtD
Betaxolol—Pain—Paclitaxel—lung cancer	0.000187	0.000337	CcSEcCtD
Betaxolol—Confusional state—Docetaxel—lung cancer	0.000187	0.000337	CcSEcCtD
Betaxolol—Pharyngitis—Methotrexate—lung cancer	0.000187	0.000337	CcSEcCtD
Betaxolol—Oedema—Docetaxel—lung cancer	0.000186	0.000334	CcSEcCtD
Betaxolol—Weight increased—Doxorubicin—lung cancer	0.000186	0.000334	CcSEcCtD
Betaxolol—Pruritus—Gemcitabine—lung cancer	0.000185	0.000333	CcSEcCtD
Betaxolol—Infection—Docetaxel—lung cancer	0.000185	0.000332	CcSEcCtD
Betaxolol—Weight decreased—Doxorubicin—lung cancer	0.000184	0.000332	CcSEcCtD
Betaxolol—Feeling abnormal—Etoposide—lung cancer	0.000184	0.000332	CcSEcCtD
Betaxolol—Hyperglycaemia—Doxorubicin—lung cancer	0.000184	0.000331	CcSEcCtD
Betaxolol—Diarrhoea—Irinotecan—lung cancer	0.000184	0.000331	CcSEcCtD
Betaxolol—Pneumonia—Doxorubicin—lung cancer	0.000183	0.000329	CcSEcCtD
Betaxolol—Shock—Docetaxel—lung cancer	0.000183	0.000329	CcSEcCtD
Betaxolol—Nervous system disorder—Docetaxel—lung cancer	0.000182	0.000328	CcSEcCtD
Betaxolol—Thrombocytopenia—Docetaxel—lung cancer	0.000182	0.000327	CcSEcCtD
Betaxolol—Infestation—Doxorubicin—lung cancer	0.000182	0.000327	CcSEcCtD
Betaxolol—Infestation NOS—Doxorubicin—lung cancer	0.000182	0.000327	CcSEcCtD
Betaxolol—Visual impairment—Methotrexate—lung cancer	0.000182	0.000327	CcSEcCtD
Betaxolol—Tachycardia—Docetaxel—lung cancer	0.000181	0.000326	CcSEcCtD
Betaxolol—Feeling abnormal—Paclitaxel—lung cancer	0.000181	0.000325	CcSEcCtD
Betaxolol—Skin disorder—Docetaxel—lung cancer	0.00018	0.000325	CcSEcCtD
Betaxolol—Hypersensitivity—Cisplatin—lung cancer	0.00018	0.000324	CcSEcCtD
Betaxolol—Diarrhoea—Gemcitabine—lung cancer	0.000179	0.000322	CcSEcCtD
Betaxolol—Neuropathy peripheral—Doxorubicin—lung cancer	0.000178	0.000321	CcSEcCtD
Betaxolol—Dizziness—Irinotecan—lung cancer	0.000178	0.00032	CcSEcCtD
Betaxolol—Urticaria—Etoposide—lung cancer	0.000178	0.00032	CcSEcCtD
Betaxolol—Stomatitis—Doxorubicin—lung cancer	0.000177	0.000319	CcSEcCtD
Betaxolol—Anorexia—Docetaxel—lung cancer	0.000177	0.000319	CcSEcCtD
Betaxolol—Body temperature increased—Etoposide—lung cancer	0.000177	0.000318	CcSEcCtD
Betaxolol—Conjunctivitis—Doxorubicin—lung cancer	0.000177	0.000318	CcSEcCtD
Betaxolol—Eye disorder—Methotrexate—lung cancer	0.000176	0.000317	CcSEcCtD
Betaxolol—Tinnitus—Methotrexate—lung cancer	0.000176	0.000316	CcSEcCtD
Betaxolol—Asthenia—Cisplatin—lung cancer	0.000175	0.000315	CcSEcCtD
Betaxolol—Cardiac disorder—Methotrexate—lung cancer	0.000175	0.000315	CcSEcCtD
Betaxolol—Sweating—Doxorubicin—lung cancer	0.000174	0.000314	CcSEcCtD
Betaxolol—Urticaria—Paclitaxel—lung cancer	0.000174	0.000313	CcSEcCtD
Betaxolol—Hypotension—Docetaxel—lung cancer	0.000174	0.000312	CcSEcCtD
Betaxolol—Body temperature increased—Paclitaxel—lung cancer	0.000173	0.000312	CcSEcCtD
Betaxolol—Epistaxis—Doxorubicin—lung cancer	0.000171	0.000309	CcSEcCtD
Betaxolol—Angiopathy—Methotrexate—lung cancer	0.000171	0.000308	CcSEcCtD
Betaxolol—Vomiting—Irinotecan—lung cancer	0.000171	0.000308	CcSEcCtD
Betaxolol—Sinusitis—Doxorubicin—lung cancer	0.000171	0.000307	CcSEcCtD
Betaxolol—Immune system disorder—Methotrexate—lung cancer	0.00017	0.000306	CcSEcCtD
Betaxolol—Mediastinal disorder—Methotrexate—lung cancer	0.00017	0.000306	CcSEcCtD
Betaxolol—Agranulocytosis—Doxorubicin—lung cancer	0.00017	0.000305	CcSEcCtD
Betaxolol—Rash—Irinotecan—lung cancer	0.000169	0.000305	CcSEcCtD
Betaxolol—Dermatitis—Irinotecan—lung cancer	0.000169	0.000305	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000169	0.000305	CcSEcCtD
Betaxolol—Chills—Methotrexate—lung cancer	0.000169	0.000304	CcSEcCtD
Betaxolol—Headache—Irinotecan—lung cancer	0.000168	0.000303	CcSEcCtD
Betaxolol—Insomnia—Docetaxel—lung cancer	0.000168	0.000302	CcSEcCtD
Betaxolol—Diarrhoea—Cisplatin—lung cancer	0.000167	0.000301	CcSEcCtD
Betaxolol—Paraesthesia—Docetaxel—lung cancer	0.000167	0.0003	CcSEcCtD
Betaxolol—Alopecia—Methotrexate—lung cancer	0.000167	0.0003	CcSEcCtD
Betaxolol—Vomiting—Gemcitabine—lung cancer	0.000166	0.0003	CcSEcCtD
Betaxolol—Bradycardia—Doxorubicin—lung cancer	0.000166	0.000299	CcSEcCtD
Betaxolol—Dyspnoea—Docetaxel—lung cancer	0.000166	0.000298	CcSEcCtD
Betaxolol—Mental disorder—Methotrexate—lung cancer	0.000165	0.000297	CcSEcCtD
Betaxolol—Rash—Gemcitabine—lung cancer	0.000165	0.000297	CcSEcCtD
Betaxolol—Dermatitis—Gemcitabine—lung cancer	0.000165	0.000297	CcSEcCtD
Betaxolol—Hypersensitivity—Etoposide—lung cancer	0.000165	0.000296	CcSEcCtD
Betaxolol—Erythema—Methotrexate—lung cancer	0.000164	0.000295	CcSEcCtD
Betaxolol—Malnutrition—Methotrexate—lung cancer	0.000164	0.000295	CcSEcCtD
Betaxolol—Headache—Gemcitabine—lung cancer	0.000164	0.000295	CcSEcCtD
Betaxolol—Rhinitis—Doxorubicin—lung cancer	0.000164	0.000295	CcSEcCtD
Betaxolol—Dyspepsia—Docetaxel—lung cancer	0.000164	0.000294	CcSEcCtD
Betaxolol—Hypoaesthesia—Doxorubicin—lung cancer	0.000162	0.000292	CcSEcCtD
Betaxolol—Pharyngitis—Doxorubicin—lung cancer	0.000162	0.000292	CcSEcCtD
Betaxolol—Decreased appetite—Docetaxel—lung cancer	0.000162	0.000291	CcSEcCtD
Betaxolol—Hypersensitivity—Paclitaxel—lung cancer	0.000162	0.000291	CcSEcCtD
Betaxolol—Dysgeusia—Methotrexate—lung cancer	0.000161	0.000289	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Docetaxel—lung cancer	0.00016	0.000289	CcSEcCtD
Betaxolol—Asthenia—Etoposide—lung cancer	0.00016	0.000289	CcSEcCtD
Betaxolol—Fatigue—Docetaxel—lung cancer	0.00016	0.000288	CcSEcCtD
Betaxolol—Nausea—Irinotecan—lung cancer	0.00016	0.000287	CcSEcCtD
Betaxolol—Constipation—Docetaxel—lung cancer	0.000159	0.000286	CcSEcCtD
Betaxolol—Pain—Docetaxel—lung cancer	0.000159	0.000286	CcSEcCtD
Betaxolol—Pruritus—Etoposide—lung cancer	0.000158	0.000285	CcSEcCtD
Betaxolol—Visual impairment—Doxorubicin—lung cancer	0.000157	0.000283	CcSEcCtD
Betaxolol—Asthenia—Paclitaxel—lung cancer	0.000157	0.000283	CcSEcCtD
Betaxolol—Nausea—Gemcitabine—lung cancer	0.000156	0.00028	CcSEcCtD
Betaxolol—Vomiting—Cisplatin—lung cancer	0.000155	0.000279	CcSEcCtD
Betaxolol—Pruritus—Paclitaxel—lung cancer	0.000155	0.000279	CcSEcCtD
Betaxolol—Vision blurred—Methotrexate—lung cancer	0.000155	0.000278	CcSEcCtD
Betaxolol—Rash—Cisplatin—lung cancer	0.000154	0.000277	CcSEcCtD
Betaxolol—Dermatitis—Cisplatin—lung cancer	0.000154	0.000277	CcSEcCtD
Betaxolol—Feeling abnormal—Docetaxel—lung cancer	0.000153	0.000276	CcSEcCtD
Betaxolol—Diarrhoea—Etoposide—lung cancer	0.000153	0.000275	CcSEcCtD
Betaxolol—Eye disorder—Doxorubicin—lung cancer	0.000153	0.000275	CcSEcCtD
Betaxolol—Ill-defined disorder—Methotrexate—lung cancer	0.000152	0.000274	CcSEcCtD
Betaxolol—Tinnitus—Doxorubicin—lung cancer	0.000152	0.000274	CcSEcCtD
Betaxolol—Anaemia—Methotrexate—lung cancer	0.000152	0.000273	CcSEcCtD
Betaxolol—Cardiac disorder—Doxorubicin—lung cancer	0.000151	0.000273	CcSEcCtD
Betaxolol—Flushing—Doxorubicin—lung cancer	0.000151	0.000273	CcSEcCtD
Betaxolol—Diarrhoea—Paclitaxel—lung cancer	0.00015	0.00027	CcSEcCtD
Betaxolol—Angiopathy—Doxorubicin—lung cancer	0.000148	0.000267	CcSEcCtD
Betaxolol—Malaise—Methotrexate—lung cancer	0.000148	0.000266	CcSEcCtD
Betaxolol—Dizziness—Etoposide—lung cancer	0.000148	0.000266	CcSEcCtD
Betaxolol—Immune system disorder—Doxorubicin—lung cancer	0.000147	0.000265	CcSEcCtD
Betaxolol—Vertigo—Methotrexate—lung cancer	0.000147	0.000265	CcSEcCtD
Betaxolol—Mediastinal disorder—Doxorubicin—lung cancer	0.000147	0.000265	CcSEcCtD
Betaxolol—Body temperature increased—Docetaxel—lung cancer	0.000147	0.000264	CcSEcCtD
Betaxolol—Chills—Doxorubicin—lung cancer	0.000146	0.000264	CcSEcCtD
Betaxolol—Arrhythmia—Doxorubicin—lung cancer	0.000146	0.000262	CcSEcCtD
Betaxolol—Dizziness—Paclitaxel—lung cancer	0.000145	0.000261	CcSEcCtD
Betaxolol—Nausea—Cisplatin—lung cancer	0.000145	0.000261	CcSEcCtD
Betaxolol—Alopecia—Doxorubicin—lung cancer	0.000144	0.00026	CcSEcCtD
Betaxolol—Cough—Methotrexate—lung cancer	0.000143	0.000258	CcSEcCtD
Betaxolol—Mental disorder—Doxorubicin—lung cancer	0.000143	0.000257	CcSEcCtD
Betaxolol—Vomiting—Etoposide—lung cancer	0.000142	0.000256	CcSEcCtD
Betaxolol—Erythema—Doxorubicin—lung cancer	0.000142	0.000256	CcSEcCtD
Betaxolol—Malnutrition—Doxorubicin—lung cancer	0.000142	0.000256	CcSEcCtD
Betaxolol—Rash—Etoposide—lung cancer	0.000141	0.000254	CcSEcCtD
Betaxolol—Dermatitis—Etoposide—lung cancer	0.000141	0.000253	CcSEcCtD
Betaxolol—Headache—Etoposide—lung cancer	0.00014	0.000252	CcSEcCtD
Betaxolol—Myalgia—Methotrexate—lung cancer	0.00014	0.000251	CcSEcCtD
Betaxolol—Chest pain—Methotrexate—lung cancer	0.00014	0.000251	CcSEcCtD
Betaxolol—Arthralgia—Methotrexate—lung cancer	0.00014	0.000251	CcSEcCtD
Betaxolol—Tension—Doxorubicin—lung cancer	0.000139	0.000251	CcSEcCtD
Betaxolol—Vomiting—Paclitaxel—lung cancer	0.000139	0.000251	CcSEcCtD
Betaxolol—Dysgeusia—Doxorubicin—lung cancer	0.000139	0.00025	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000139	0.00025	CcSEcCtD
Betaxolol—Rash—Paclitaxel—lung cancer	0.000138	0.000249	CcSEcCtD
Betaxolol—Dermatitis—Paclitaxel—lung cancer	0.000138	0.000249	CcSEcCtD
Betaxolol—Discomfort—Methotrexate—lung cancer	0.000138	0.000248	CcSEcCtD
Betaxolol—Nervousness—Doxorubicin—lung cancer	0.000138	0.000248	CcSEcCtD
Betaxolol—Headache—Paclitaxel—lung cancer	0.000137	0.000247	CcSEcCtD
Betaxolol—Hypersensitivity—Docetaxel—lung cancer	0.000137	0.000246	CcSEcCtD
Betaxolol—Muscle spasms—Doxorubicin—lung cancer	0.000137	0.000246	CcSEcCtD
Betaxolol—Confusional state—Methotrexate—lung cancer	0.000135	0.000243	CcSEcCtD
Betaxolol—Vision blurred—Doxorubicin—lung cancer	0.000134	0.000241	CcSEcCtD
Betaxolol—Asthenia—Docetaxel—lung cancer	0.000133	0.00024	CcSEcCtD
Betaxolol—Infection—Methotrexate—lung cancer	0.000133	0.000239	CcSEcCtD
Betaxolol—Nausea—Etoposide—lung cancer	0.000133	0.000239	CcSEcCtD
Betaxolol—Ill-defined disorder—Doxorubicin—lung cancer	0.000132	0.000237	CcSEcCtD
Betaxolol—Pruritus—Docetaxel—lung cancer	0.000131	0.000237	CcSEcCtD
Betaxolol—Nervous system disorder—Methotrexate—lung cancer	0.000131	0.000236	CcSEcCtD
Betaxolol—Anaemia—Doxorubicin—lung cancer	0.000131	0.000236	CcSEcCtD
Betaxolol—Thrombocytopenia—Methotrexate—lung cancer	0.000131	0.000236	CcSEcCtD
Betaxolol—Nausea—Paclitaxel—lung cancer	0.00013	0.000234	CcSEcCtD
Betaxolol—Skin disorder—Methotrexate—lung cancer	0.00013	0.000234	CcSEcCtD
Betaxolol—Hyperhidrosis—Methotrexate—lung cancer	0.000129	0.000233	CcSEcCtD
Betaxolol—Malaise—Doxorubicin—lung cancer	0.000128	0.000231	CcSEcCtD
Betaxolol—Vertigo—Doxorubicin—lung cancer	0.000128	0.00023	CcSEcCtD
Betaxolol—Anorexia—Methotrexate—lung cancer	0.000128	0.00023	CcSEcCtD
Betaxolol—Syncope—Doxorubicin—lung cancer	0.000127	0.000229	CcSEcCtD
Betaxolol—Diarrhoea—Docetaxel—lung cancer	0.000127	0.000229	CcSEcCtD
Betaxolol—Palpitations—Doxorubicin—lung cancer	0.000126	0.000226	CcSEcCtD
Betaxolol—Hypotension—Methotrexate—lung cancer	0.000125	0.000225	CcSEcCtD
Betaxolol—Loss of consciousness—Doxorubicin—lung cancer	0.000125	0.000225	CcSEcCtD
Betaxolol—Cough—Doxorubicin—lung cancer	0.000124	0.000223	CcSEcCtD
Betaxolol—Dizziness—Docetaxel—lung cancer	0.000123	0.000221	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000122	0.00022	CcSEcCtD
Betaxolol—Insomnia—Methotrexate—lung cancer	0.000121	0.000218	CcSEcCtD
Betaxolol—Myalgia—Doxorubicin—lung cancer	0.000121	0.000218	CcSEcCtD
Betaxolol—Arthralgia—Doxorubicin—lung cancer	0.000121	0.000218	CcSEcCtD
Betaxolol—Chest pain—Doxorubicin—lung cancer	0.000121	0.000218	CcSEcCtD
Betaxolol—Anxiety—Doxorubicin—lung cancer	0.000121	0.000217	CcSEcCtD
Betaxolol—Paraesthesia—Methotrexate—lung cancer	0.00012	0.000216	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.00012	0.000216	CcSEcCtD
Betaxolol—Discomfort—Doxorubicin—lung cancer	0.00012	0.000215	CcSEcCtD
Betaxolol—Dyspnoea—Methotrexate—lung cancer	0.000119	0.000215	CcSEcCtD
Betaxolol—Dry mouth—Doxorubicin—lung cancer	0.000118	0.000213	CcSEcCtD
Betaxolol—Vomiting—Docetaxel—lung cancer	0.000118	0.000213	CcSEcCtD
Betaxolol—Dyspepsia—Methotrexate—lung cancer	0.000118	0.000212	CcSEcCtD
Betaxolol—Rash—Docetaxel—lung cancer	0.000117	0.000211	CcSEcCtD
Betaxolol—Dermatitis—Docetaxel—lung cancer	0.000117	0.000211	CcSEcCtD
Betaxolol—Confusional state—Doxorubicin—lung cancer	0.000117	0.00021	CcSEcCtD
Betaxolol—Decreased appetite—Methotrexate—lung cancer	0.000116	0.00021	CcSEcCtD
Betaxolol—Headache—Docetaxel—lung cancer	0.000116	0.00021	CcSEcCtD
Betaxolol—Oedema—Doxorubicin—lung cancer	0.000116	0.000209	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Methotrexate—lung cancer	0.000116	0.000208	CcSEcCtD
Betaxolol—Fatigue—Methotrexate—lung cancer	0.000115	0.000208	CcSEcCtD
Betaxolol—Infection—Doxorubicin—lung cancer	0.000115	0.000207	CcSEcCtD
Betaxolol—Pain—Methotrexate—lung cancer	0.000115	0.000206	CcSEcCtD
Betaxolol—Shock—Doxorubicin—lung cancer	0.000114	0.000205	CcSEcCtD
Betaxolol—Nervous system disorder—Doxorubicin—lung cancer	0.000114	0.000205	CcSEcCtD
Betaxolol—Thrombocytopenia—Doxorubicin—lung cancer	0.000114	0.000204	CcSEcCtD
Betaxolol—Tachycardia—Doxorubicin—lung cancer	0.000113	0.000204	CcSEcCtD
Betaxolol—Skin disorder—Doxorubicin—lung cancer	0.000113	0.000203	CcSEcCtD
Betaxolol—Hyperhidrosis—Doxorubicin—lung cancer	0.000112	0.000202	CcSEcCtD
Betaxolol—Anorexia—Doxorubicin—lung cancer	0.000111	0.000199	CcSEcCtD
Betaxolol—Nausea—Docetaxel—lung cancer	0.00011	0.000199	CcSEcCtD
Betaxolol—Feeling abnormal—Methotrexate—lung cancer	0.00011	0.000199	CcSEcCtD
Betaxolol—Hypotension—Doxorubicin—lung cancer	0.000108	0.000195	CcSEcCtD
Betaxolol—Urticaria—Methotrexate—lung cancer	0.000106	0.000191	CcSEcCtD
Betaxolol—Body temperature increased—Methotrexate—lung cancer	0.000106	0.000191	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000106	0.00019	CcSEcCtD
Betaxolol—Insomnia—Doxorubicin—lung cancer	0.000105	0.000189	CcSEcCtD
Betaxolol—Paraesthesia—Doxorubicin—lung cancer	0.000104	0.000187	CcSEcCtD
Betaxolol—Dyspnoea—Doxorubicin—lung cancer	0.000103	0.000186	CcSEcCtD
Betaxolol—Dyspepsia—Doxorubicin—lung cancer	0.000102	0.000184	CcSEcCtD
Betaxolol—Decreased appetite—Doxorubicin—lung cancer	0.000101	0.000181	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Doxorubicin—lung cancer	0.0001	0.00018	CcSEcCtD
Betaxolol—Fatigue—Doxorubicin—lung cancer	0.0001	0.00018	CcSEcCtD
Betaxolol—Constipation—Doxorubicin—lung cancer	9.92e-05	0.000178	CcSEcCtD
Betaxolol—Pain—Doxorubicin—lung cancer	9.92e-05	0.000178	CcSEcCtD
Betaxolol—Hypersensitivity—Methotrexate—lung cancer	9.87e-05	0.000178	CcSEcCtD
Betaxolol—Asthenia—Methotrexate—lung cancer	9.61e-05	0.000173	CcSEcCtD
Betaxolol—Feeling abnormal—Doxorubicin—lung cancer	9.56e-05	0.000172	CcSEcCtD
Betaxolol—Pruritus—Methotrexate—lung cancer	9.47e-05	0.000171	CcSEcCtD
Betaxolol—Urticaria—Doxorubicin—lung cancer	9.21e-05	0.000166	CcSEcCtD
Betaxolol—Body temperature increased—Doxorubicin—lung cancer	9.17e-05	0.000165	CcSEcCtD
Betaxolol—Diarrhoea—Methotrexate—lung cancer	9.16e-05	0.000165	CcSEcCtD
Betaxolol—Dizziness—Methotrexate—lung cancer	8.86e-05	0.000159	CcSEcCtD
Betaxolol—Hypersensitivity—Doxorubicin—lung cancer	8.54e-05	0.000154	CcSEcCtD
Betaxolol—Vomiting—Methotrexate—lung cancer	8.51e-05	0.000153	CcSEcCtD
Betaxolol—Rash—Methotrexate—lung cancer	8.44e-05	0.000152	CcSEcCtD
Betaxolol—Dermatitis—Methotrexate—lung cancer	8.44e-05	0.000152	CcSEcCtD
Betaxolol—Headache—Methotrexate—lung cancer	8.39e-05	0.000151	CcSEcCtD
Betaxolol—Asthenia—Doxorubicin—lung cancer	8.32e-05	0.00015	CcSEcCtD
Betaxolol—Pruritus—Doxorubicin—lung cancer	8.2e-05	0.000148	CcSEcCtD
Betaxolol—Nausea—Methotrexate—lung cancer	7.95e-05	0.000143	CcSEcCtD
Betaxolol—Diarrhoea—Doxorubicin—lung cancer	7.93e-05	0.000143	CcSEcCtD
Betaxolol—Dizziness—Doxorubicin—lung cancer	7.67e-05	0.000138	CcSEcCtD
Betaxolol—Vomiting—Doxorubicin—lung cancer	7.37e-05	0.000133	CcSEcCtD
Betaxolol—Rash—Doxorubicin—lung cancer	7.31e-05	0.000132	CcSEcCtD
Betaxolol—Dermatitis—Doxorubicin—lung cancer	7.3e-05	0.000131	CcSEcCtD
Betaxolol—Headache—Doxorubicin—lung cancer	7.26e-05	0.000131	CcSEcCtD
Betaxolol—Nausea—Doxorubicin—lung cancer	6.89e-05	0.000124	CcSEcCtD
Betaxolol—ADRB2—Signaling Pathways—FLT1—lung cancer	4.05e-05	0.000388	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—FGF9—lung cancer	4.02e-05	0.000385	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—PIK3CG—lung cancer	4.02e-05	0.000384	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—APP—lung cancer	3.97e-05	0.00038	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—NOTCH3—lung cancer	3.97e-05	0.00038	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—FGF9—lung cancer	3.94e-05	0.000377	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CYP2A7—lung cancer	3.93e-05	0.000376	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—POMC—lung cancer	3.91e-05	0.000374	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—B4GALT5—lung cancer	3.89e-05	0.000372	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—SDC4—lung cancer	3.85e-05	0.000368	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—JUNB—lung cancer	3.84e-05	0.000368	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—POMC—lung cancer	3.82e-05	0.000366	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GSTA4—lung cancer	3.78e-05	0.000362	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—JUNB—lung cancer	3.76e-05	0.00036	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—PIK3CG—lung cancer	3.73e-05	0.000357	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GSTA2—lung cancer	3.69e-05	0.000353	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—PIK3CG—lung cancer	3.65e-05	0.000349	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—PIK3CD—lung cancer	3.61e-05	0.000345	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GSTA1—lung cancer	3.56e-05	0.000341	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—POMC—lung cancer	3.55e-05	0.00034	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—PIK3CD—lung cancer	3.53e-05	0.000338	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ABCC3—lung cancer	3.52e-05	0.000337	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—RRM1—lung cancer	3.51e-05	0.000335	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GSTA3—lung cancer	3.51e-05	0.000335	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—STK11—lung cancer	3.49e-05	0.000334	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—POMC—lung cancer	3.47e-05	0.000332	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—IL6R—lung cancer	3.46e-05	0.000331	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—STK11—lung cancer	3.41e-05	0.000327	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—AKR1C1—lung cancer	3.41e-05	0.000326	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—IL6R—lung cancer	3.39e-05	0.000324	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—FOXO3—lung cancer	3.37e-05	0.000322	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—UGT1A1—lung cancer	3.31e-05	0.000317	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—MAP2K1—lung cancer	3.3e-05	0.000316	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—B4GALT5—lung cancer	3.3e-05	0.000315	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—FOXO3—lung cancer	3.29e-05	0.000315	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—PIK3CD—lung cancer	3.28e-05	0.000314	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—MAP2K1—lung cancer	3.23e-05	0.000309	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—PIK3CD—lung cancer	3.21e-05	0.000307	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GSTA4—lung cancer	3.21e-05	0.000307	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GNG11—lung cancer	3.19e-05	0.000305	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—AVP—lung cancer	3.15e-05	0.000302	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—PIK3CB—lung cancer	3.15e-05	0.000301	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	3.13e-05	0.0003	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GSTA2—lung cancer	3.12e-05	0.000299	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—AVP—lung cancer	3.09e-05	0.000295	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—PIK3CB—lung cancer	3.08e-05	0.000294	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ALDOA—lung cancer	3.04e-05	0.000291	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—IGF1R—lung cancer	3.04e-05	0.000291	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—CXCL8—lung cancer	3.02e-05	0.000289	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GSTA1—lung cancer	3.01e-05	0.000288	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—HES1—lung cancer	2.98e-05	0.000285	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ABCC3—lung cancer	2.98e-05	0.000285	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—IGF1R—lung cancer	2.97e-05	0.000284	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—CXCL8—lung cancer	2.96e-05	0.000283	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—NCOA3—lung cancer	2.95e-05	0.000282	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—RAF1—lung cancer	2.93e-05	0.00028	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—HES1—lung cancer	2.92e-05	0.000279	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—IL2—lung cancer	2.89e-05	0.000276	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—AKR1C1—lung cancer	2.89e-05	0.000276	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ABCG2—lung cancer	2.87e-05	0.000274	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ADCY1—lung cancer	2.87e-05	0.000274	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—RAF1—lung cancer	2.86e-05	0.000274	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—PIK3CB—lung cancer	2.86e-05	0.000273	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—IL2—lung cancer	2.83e-05	0.00027	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ENO2—lung cancer	2.81e-05	0.000269	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—HPGDS—lung cancer	2.81e-05	0.000269	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—UGT1A1—lung cancer	2.8e-05	0.000268	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PPP2R1B—lung cancer	2.79e-05	0.000267	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—PIK3CB—lung cancer	2.79e-05	0.000267	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—CXCL8—lung cancer	2.75e-05	0.000263	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GSTT1—lung cancer	2.73e-05	0.000261	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—ERBB3—lung cancer	2.73e-05	0.000261	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GNG11—lung cancer	2.7e-05	0.000259	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GCLC—lung cancer	2.7e-05	0.000258	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CYP2A6—lung cancer	2.7e-05	0.000258	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	2.69e-05	0.000257	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—CXCL8—lung cancer	2.69e-05	0.000257	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—ERBB3—lung cancer	2.67e-05	0.000255	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—IL2—lung cancer	2.62e-05	0.000251	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—TERT—lung cancer	2.61e-05	0.00025	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ALDOA—lung cancer	2.57e-05	0.000246	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—IL2—lung cancer	2.57e-05	0.000246	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—TERT—lung cancer	2.56e-05	0.000245	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ENO1—lung cancer	2.56e-05	0.000245	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—FGFR1—lung cancer	2.54e-05	0.000243	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—HIF1A—lung cancer	2.5e-05	0.000239	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—NCOA3—lung cancer	2.5e-05	0.000239	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—FGFR1—lung cancer	2.48e-05	0.000238	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	2.45e-05	0.000235	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—HIF1A—lung cancer	2.45e-05	0.000234	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ADCY1—lung cancer	2.43e-05	0.000233	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ABCG2—lung cancer	2.43e-05	0.000233	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—APOA1—lung cancer	2.41e-05	0.000231	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—KDR—lung cancer	2.39e-05	0.000229	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ENO2—lung cancer	2.38e-05	0.000228	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—HPGDS—lung cancer	2.38e-05	0.000228	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PPP2R1B—lung cancer	2.37e-05	0.000227	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—APOA1—lung cancer	2.36e-05	0.000226	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—KDR—lung cancer	2.34e-05	0.000224	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	2.34e-05	0.000224	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GSTT1—lung cancer	2.31e-05	0.000221	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CYP2E1—lung cancer	2.29e-05	0.000219	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GCLC—lung cancer	2.28e-05	0.000219	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CYP2A6—lung cancer	2.28e-05	0.000219	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.28e-05	0.000218	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—NQO1—lung cancer	2.27e-05	0.000217	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—KIT—lung cancer	2.2e-05	0.000211	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PIK3CG—lung cancer	2.2e-05	0.000211	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—APC—lung cancer	2.2e-05	0.000211	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—NRAS—lung cancer	2.2e-05	0.000211	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—EGF—lung cancer	2.18e-05	0.000208	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ENO1—lung cancer	2.17e-05	0.000207	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.16e-05	0.000206	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—APC—lung cancer	2.15e-05	0.000206	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PIK3CG—lung cancer	2.15e-05	0.000206	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—KIT—lung cancer	2.15e-05	0.000206	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—NRAS—lung cancer	2.15e-05	0.000206	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.13e-05	0.000204	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—EGF—lung cancer	2.13e-05	0.000204	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—MAPK3—lung cancer	2.11e-05	0.000202	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—POMC—lung cancer	2.1e-05	0.000201	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—BRAF—lung cancer	2.07e-05	0.000198	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—MAPK3—lung cancer	2.06e-05	0.000197	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—POMC—lung cancer	2.05e-05	0.000196	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—IL6R—lung cancer	2.04e-05	0.000196	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—STK11—lung cancer	2.04e-05	0.000196	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CREBBP—lung cancer	2.04e-05	0.000195	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—BRAF—lung cancer	2.02e-05	0.000194	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—EGFR—lung cancer	2.01e-05	0.000192	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—IL6R—lung cancer	2e-05	0.000191	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CREBBP—lung cancer	2e-05	0.000191	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—EGFR—lung cancer	1.96e-05	0.000188	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—MAP2K1—lung cancer	1.95e-05	0.000187	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CYP2E1—lung cancer	1.94e-05	0.000186	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PIK3CD—lung cancer	1.94e-05	0.000185	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—NQO1—lung cancer	1.92e-05	0.000184	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—PIK3CA—lung cancer	1.92e-05	0.000184	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—MAP2K1—lung cancer	1.91e-05	0.000182	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—KRAS—lung cancer	1.9e-05	0.000181	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PIK3CD—lung cancer	1.89e-05	0.000181	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GSTP1—lung cancer	1.89e-05	0.000181	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.88e-05	0.00018	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—PIK3CA—lung cancer	1.88e-05	0.00018	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.86e-05	0.000178	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—KRAS—lung cancer	1.85e-05	0.000177	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CAT—lung cancer	1.84e-05	0.000176	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ABCB1—lung cancer	1.79e-05	0.000171	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—TYMS—lung cancer	1.76e-05	0.000168	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—PIK3CA—lung cancer	1.74e-05	0.000167	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GSTM1—lung cancer	1.74e-05	0.000166	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—MDM2—lung cancer	1.73e-05	0.000166	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—STK11—lung cancer	1.73e-05	0.000166	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—RAF1—lung cancer	1.73e-05	0.000165	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—ERBB2—lung cancer	1.71e-05	0.000164	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—PIK3CA—lung cancer	1.7e-05	0.000163	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—MDM2—lung cancer	1.7e-05	0.000162	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—RAF1—lung cancer	1.69e-05	0.000162	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PIK3CB—lung cancer	1.69e-05	0.000161	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—MTOR—lung cancer	1.69e-05	0.000161	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—ERBB2—lung cancer	1.67e-05	0.00016	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—MTOR—lung cancer	1.65e-05	0.000158	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PIK3CB—lung cancer	1.65e-05	0.000158	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CYP1A1—lung cancer	1.65e-05	0.000158	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ERCC2—lung cancer	1.63e-05	0.000156	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.63e-05	0.000156	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CXCL8—lung cancer	1.62e-05	0.000155	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—HRAS—lung cancer	1.61e-05	0.000154	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GSTP1—lung cancer	1.6e-05	0.000153	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CXCL8—lung cancer	1.59e-05	0.000152	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—HRAS—lung cancer	1.58e-05	0.000151	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—AKT1—lung cancer	1.57e-05	0.00015	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CAT—lung cancer	1.56e-05	0.000149	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CASP3—lung cancer	1.55e-05	0.000149	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.55e-05	0.000148	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—IL2—lung cancer	1.55e-05	0.000148	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—IL6—lung cancer	1.54e-05	0.000148	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—AKT1—lung cancer	1.53e-05	0.000147	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CASP3—lung cancer	1.52e-05	0.000145	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ABCB1—lung cancer	1.52e-05	0.000145	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—IL2—lung cancer	1.52e-05	0.000145	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CCND1—lung cancer	1.51e-05	0.000145	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—IL6—lung cancer	1.51e-05	0.000144	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—JUN—lung cancer	1.51e-05	0.000144	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—TYMS—lung cancer	1.49e-05	0.000143	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CCND1—lung cancer	1.48e-05	0.000141	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—JUN—lung cancer	1.47e-05	0.000141	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GSTM1—lung cancer	1.47e-05	0.000141	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—MMP9—lung cancer	1.47e-05	0.00014	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CDKN1A—lung cancer	1.46e-05	0.00014	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PTEN—lung cancer	1.46e-05	0.00014	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—MMP9—lung cancer	1.43e-05	0.000137	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CDKN1A—lung cancer	1.43e-05	0.000137	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PTEN—lung cancer	1.43e-05	0.000137	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—AKT1—lung cancer	1.42e-05	0.000136	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—APOA1—lung cancer	1.41e-05	0.000135	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CYP1A1—lung cancer	1.4e-05	0.000134	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—AKT1—lung cancer	1.39e-05	0.000133	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—EP300—lung cancer	1.39e-05	0.000133	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ERCC2—lung cancer	1.38e-05	0.000132	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—EP300—lung cancer	1.36e-05	0.00013	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—SRC—lung cancer	1.35e-05	0.000129	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—SRC—lung cancer	1.32e-05	0.000127	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—VEGFA—lung cancer	1.32e-05	0.000126	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—STAT3—lung cancer	1.3e-05	0.000125	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—NRAS—lung cancer	1.3e-05	0.000125	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PIK3CG—lung cancer	1.29e-05	0.000123	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—VEGFA—lung cancer	1.29e-05	0.000123	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—STAT3—lung cancer	1.28e-05	0.000122	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—NRAS—lung cancer	1.27e-05	0.000122	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—MAPK3—lung cancer	1.25e-05	0.000119	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—POMC—lung cancer	1.23e-05	0.000118	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—MAPK3—lung cancer	1.22e-05	0.000117	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—MYC—lung cancer	1.21e-05	0.000116	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—APOA1—lung cancer	1.2e-05	0.000115	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CREBBP—lung cancer	1.2e-05	0.000114	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—MYC—lung cancer	1.19e-05	0.000113	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—EGFR—lung cancer	1.19e-05	0.000113	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—EGFR—lung cancer	1.16e-05	0.000111	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.15e-05	0.00011	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PIK3CD—lung cancer	1.13e-05	0.000109	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—KRAS—lung cancer	1.12e-05	0.000107	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ALB—lung cancer	1.12e-05	0.000107	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—KRAS—lung cancer	1.1e-05	0.000105	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PIK3CG—lung cancer	1.09e-05	0.000105	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—POMC—lung cancer	1.04e-05	9.96e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PIK3CA—lung cancer	1.03e-05	9.85e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CREBBP—lung cancer	1.01e-05	9.7e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PIK3CA—lung cancer	1.01e-05	9.63e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—TP53—lung cancer	9.95e-06	9.52e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PIK3CB—lung cancer	9.89e-06	9.46e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PTGS2—lung cancer	9.8e-06	9.38e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—TP53—lung cancer	9.73e-06	9.32e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PIK3CD—lung cancer	9.61e-06	9.2e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—HRAS—lung cancer	9.52e-06	9.11e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ALB—lung cancer	9.49e-06	9.08e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—HRAS—lung cancer	9.31e-06	8.91e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—IL6—lung cancer	9.11e-06	8.72e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—IL6—lung cancer	8.91e-06	8.53e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PTEN—lung cancer	8.54e-06	8.18e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—AKT1—lung cancer	8.4e-06	8.04e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PIK3CB—lung cancer	8.38e-06	8.02e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PTGS2—lung cancer	8.3e-06	7.94e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—AKT1—lung cancer	8.22e-06	7.87e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—EP300—lung cancer	8.15e-06	7.8e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PTEN—lung cancer	7.24e-06	6.93e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—EP300—lung cancer	6.9e-06	6.61e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PIK3CA—lung cancer	6.03e-06	5.77e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PIK3CA—lung cancer	5.11e-06	4.89e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—AKT1—lung cancer	4.92e-06	4.71e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—AKT1—lung cancer	4.17e-06	3.99e-05	CbGpPWpGaD
